Gilead Sciences, Inc. (GIS)
XETR
Closed
Oct 6, 2026
Day's Range
127.2852 wk Range
32.82Overview - GIS - Gilead Sciences, Inc.
Key Statistics
Valuation
Enterprise Value
160.99B
P/E (Trailing)
‪17.68‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪5.23‬
Price / Book
‪15.66‬
EV / EBITDA
‪12.38‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.21%‬
Price stats
Beta
‪0.35‬
50-Day Avg
‪124.06‬
200-Day Avg
‪117.99‬
Dividends
Payout Ratio
‪43.40%‬
Frequency
Quarterly
Market Cap - GIS - Gilead Sciences, Inc.
Peers - GIS - Gilead Sciences, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
- GISXETRGilead Sciences, Inc.159.58BMarket Cap+24.96%52-week change17.69P/E (Trailing)‪-10.63%‬Profit Margin
- LLYXETREli Lilly and Company906.86BMarket Cap+28.61%52-week change38.47P/E (Trailing)‪33.52%‬Profit Margin
- JNJXETRJohnson & Johnson571.02BMarket Cap+35.08%52-week change31.26P/E (Trailing)‪21.48%‬Profit Margin
- 4ABXETRAbbVie Inc.408.02BMarket Cap+18.23%52-week change74.71P/E (Trailing)‪9.80%‬Profit Margin
- RHOXETRRoche Holding AG315.83BMarket Cap+27.70%52-week change24.33P/E (Trailing)‪19.60%‬Profit Margin
- 6MKXETRMerck & Co., Inc.314.56BMarket Cap+40.53%52-week change114.86P/E (Trailing)‪4.76%‬Profit Margin
- ZEGXETRAstraZeneca PLC249.22BMarket Cap+21.38%52-week change28.34P/E (Trailing)‪17.02%‬Profit Margin
Profile Summary - GIS - Gilead Sciences, Inc.
About
Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases with unmet medical needs. Gilead Sciences specializes in therapeutic areas including HIV, viral hepatitis, oncology, inflammation, respiratory conditions, and cardiovascular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
